Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01359540 · ClinicalTrials.gov registry record
Femoral Remodeling Following Total Hip Arthroplasty With OMNI Apex Modular™ and OMNI Apex ARC™ Stem Compared to Competitive Designs
A clinical trial, sponsored by Spokane Joint Replacement Center.
- Completed
- Registry status
- 73
- Enrollment target
NCT01359540: Completed study, sponsored by Spokane Joint Replacement Center.
NCT01359540 is a clinical trial that has completed, run by Spokane Joint Replacement Center. The registered enrollment target is 73 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01359540 has completed, sponsored by Spokane Joint Replacement Center.
- COMPLETED
- Registry status
- 73 participants
- Enrollment target
Study Summary
This study compares the change in bone density which occurs after hip replacement with different femoral stem devices.
Primary Outcome
Change in bone mineral density (BMD) as measured by DXA imaging.
Interventions
- DEVICE OMNI Apex Modular™ Hip Device
- DEVICE OMNI Apex ARC™ Hip Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2009-11 |
| Est. Completion | 2018-04 |
What the finished NCT01359540 record still lists
NCT01359540 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 73 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which OMNI Apex Modular™ Hip Device is the first listed.
NCT01359540 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01359540 about?
NCT01359540 is a clinical study titled "Femoral Remodeling Following Total Hip Arthroplasty With OMNI Apex Modular™ and OMNI Apex ARC™ Stem Compared to Competitive Designs". This study compares the change in bone density which occurs after hip replacement with different femoral stem devices.
What is the current status of trial NCT01359540?
This trial is currently completed. The enrollment target is 73 participants. The study started on 2009-11. Estimated completion is 2018-04.
What interventions are being tested in trial NCT01359540?
The interventions under investigation include: OMNI Apex Modular™ Hip Device (DEVICE), OMNI Apex ARC™ Hip Device (DEVICE).
Who is sponsoring clinical trial NCT01359540?
This trial is sponsored by Spokane Joint Replacement Center, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia